Genetic Technologies Limited
GNTLF
$0.00
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 36.34% | 34.86% | 12.21% | 14.38% | -16.50% |
| Total Depreciation and Amortization | -58.53% | -57.59% | -27.57% | -29.39% | -53.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 75.36% | 79.46% | -121.48% | -120.96% | 322.86% |
| Change in Net Operating Assets | -- | -- | 168.32% | 166.62% | -- |
| Cash from Operations | 98.23% | 98.18% | -55.67% | -51.84% | 35.17% |
| Capital Expenditure | 75.00% | 73.91% | 66.67% | 67.35% | -820.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 261.04% | 269.25% | -73.80% | -74.67% | 46.95% |
| Cash from Investing | 366.55% | 376.27% | -74.85% | -75.45% | 121.75% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -76.16% | -76.16% | -3.53% | -3.53% | -3.85% |
| Issuance of Common Stock | -- | -- | -64.07% | -64.07% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3,809.09% | -3,809.09% | 99.50% | 99.50% | -- |
| Cash from Financing | -101.40% | -106.28% | -51.42% | -52.62% | -4.39% |
| Foreign Exchange rate Adjustments | 87.80% | 87.80% | -129.49% | -128.67% | -215.49% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 99.81% | 99.81% | -195.23% | -192.88% | 38.91% |